Shopify Inc
SHOP
The Toronto-Dominion Bank
TD
Canadian Natural Resources Ltd
CNQ
4
GoldMining Inc
GOLD
5
Tesla CDR (CAD Hedged)
TSLA
CA Stock MarketDetailed Quotes
CSCI Cosciens Biopharma Inc
- 4.670
- -0.230-4.69%
15min DelayTrading Apr 30 09:56 ET
14.69MMarket Cap-0.55P/E (TTM)
4.670High4.670Low100Volume4.670Open4.900Pre Close467.00Turnover9.00052wk High0.00%Turnover Ratio3.15MShares2.90052wk Low-8.529EPS TTM13.28MFloat Cap9.000Historical HighLossP/E (Static)2.84MShs Float2.900Historical Low-8.529EPS LYR0.00%Amplitude--Dividend TTM0.80P/B1Lot Size--Div YieldTTM
Cosciens Biopharma Inc Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -464.21%-14.57M | -176.41%-3M | -5,502.08%-7.78M | -70.85%-1.39M | -189.11%-2.4M | -149.38%-2.58M | -198.46%-1.09M | -86.36%144K | -140.04%-813K | -179.61%-828.98K |
| Net income from continuing operations | -339.28%-15.31M | -330.37%-6.73M | -641.62%-5.76M | -65.35%-1.42M | -391.40%-1.4M | -201.07%-3.49M | -2,559.81%-1.56M | -234.59%-776K | -163.44%-860K | -119.60%-284.67K |
| Operating gains losses | ---2.3M | ---454K | ---136K | ---1.71M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 11.37%1.61M | 9.19%392K | 31.96%479K | 4.14%377K | -0.08%358.46K | -1.70%1.44M | -17.10%359K | 18.61%363K | 0.99%362K | -3.15%358.76K |
| Asset impairment expenditure | --4.26M | --2.8M | --1.46M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Remuneration paid in stock | 141.67%464K | -37.50%10K | 1,193.94%427K | -69.77%13K | -85.52%14.36K | 178.26%192K | 2.07%16K | 47.71%33K | 125.86%43K | 729.82%99.13K |
| Deferred tax | 108.93%79K | 399.17%1.08M | 47.17%-112K | -101.70%-474K | -428.39%-411.54K | -181.94%-885K | -1,193.93%-360K | -218.85%-212K | -156.03%-235K | -117.34%-77.89K |
| Other non cashItems | -994.74%-850K | ---845K | ---16K | --11K | -12.87%21.77K | -5.00%95K | ---- | ---- | ---- | -5.56%24.99K |
| Change In working capital | -4,434.48%-2.51M | 104.34%754K | -660.46%-4.13M | 1,578.05%1.82M | -3.76%-959.03K | 106.20%58K | -19.22%369K | 2,728.44%736K | -0.51%-123K | 25.60%-924.31K |
| -Change in receivables | ---- | ---- | -327.97%-978K | -56.74%427K | -1,762.64%-1.11M | ---- | ---- | 8.35%429K | 498.56%987K | 94.97%-59.55K |
| -Change in inventory | ---- | ---- | -21.89%-206K | 174.44%501K | 208.67%392.46K | ---- | ---- | 54.91%-169K | -54.23%-673K | -422.90%-361.13K |
| -Change in prepaid assets | ---- | ---- | 424.39%266K | 621.57%368K | -370.95%-119.76K | ---- | ---- | -778.08%-82K | -50.43%51K | 76.53%-25.43K |
| -Change in payables and accrued expense | ---- | ---- | -739.07%-3.57M | 215.78%565K | 74.38%-122.49K | ---- | ---- | 1,011.59%558K | -1,156.51%-488K | -669.26%-478.19K |
| -Change in other working capital | ---- | ---- | --359K | ---43K | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from operating activities) | ---- | ---- | ---- | ---- | 12.87%-21.77K | ---- | ---- | ---- | ---- | 5.56%-24.99K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -464.21%-14.57M | -176.41%-3M | -5,502.08%-7.78M | -70.85%-1.39M | -189.11%-2.4M | -149.38%-2.58M | -198.46%-1.09M | -86.36%144K | -140.04%-813K | -179.61%-828.98K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 3,536.03%25.08M | 46.89%-316K | 266.00%83K | 48,025.93%25.88M | -1,711.84%-563.43K | -140.13%-730K | -1,863.29%-595K | 0.75%-50K | -34.43%-54K | 83.02%-31.1K |
| Net PPE purchase and sale | -60.80%-1.16M | 47.36%-309K | -162.00%-131K | -190.74%-157K | -1,711.84%-563.43K | -137.50%-722K | -799.96%-587K | 4.80%-50K | -30.56%-54K | 78.54%-31.1K |
| Net business purchase and sale | --26.04M | --0 | --0 | --26.04M | ---- | --0 | --0 | --0 | --0 | ---- |
| Net other investing changes | 2,687.50%207K | ---7K | --214K | ---- | ---- | ---8K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 3,536.03%25.08M | 46.89%-316K | 266.00%83K | 48,025.93%25.88M | -1,711.84%-563.43K | -140.13%-730K | -1,863.29%-595K | 0.75%-50K | -34.43%-54K | 83.02%-31.1K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -64.71%-588K | -22.42%-202K | -218.64%-188K | -80.00%-126K | -15.56%-71.92K | -33.71%-357K | -0.49%-165K | -54.10%-59K | -801.90%-70K | -9.66%-62.24K |
| Net issuance payments of debt | -13.78%-421K | 33.94%-109K | -60.56%-114K | -80.00%-126K | -12.87%-71.92K | -12.12%-370K | 4.01%-165K | -51.36%-71K | -29.24%-70K | -11.70%-63.72K |
| Proceeds from stock option exercised by employees | -1,384.62%-167K | ---93K | -716.67%-74K | --0 | --0 | -79.37%13K | --0 | 39.20%12K | --0 | 412.78%1.48K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -64.71%-588K | -22.42%-202K | -218.64%-188K | -80.00%-126K | -15.56%-71.92K | -33.71%-357K | -0.49%-165K | -54.10%-59K | -801.90%-70K | -9.66%-62.24K |
| Net cash flow | ||||||||||
| Beginning cash position | -34.47%6.68M | 139.10%20M | 225.65%27.8M | -62.28%3.51M | -35.90%6.55M | 65.50%10.19M | -11.40%8.36M | -3.22%8.54M | 32.15%9.3M | 63.83%10.21M |
| Current changes in cash | 370.56%9.93M | -90.62%-3.52M | -22,625.71%-7.88M | 2,700.32%24.37M | -228.74%-3.03M | -178.77%-3.67M | -303.30%-1.85M | -96.38%35K | -147.27%-937K | -215.08%-922.32K |
| Effect of exchange rate changes | -235.03%-212K | -155.35%-88K | 137.32%78K | -137.22%-67K | ---- | 125.12%157K | --159K | ---209K | --180K | ---- |
| End cash Position | 145.48%16.39M | 145.48%16.39M | 139.10%20M | 225.65%27.8M | -62.18%3.51M | -34.47%6.68M | -34.47%6.68M | -11.40%8.36M | -3.22%8.54M | 32.05%9.29M |
| Free cash from | -376.06%-15.73M | -97.85%-3.31M | -8,514.89%-7.91M | -78.32%-1.55M | -244.16%-2.96M | -167.09%-3.3M | -261.27%-1.67M | -90.63%94K | -143.59%-867K | -195.94%-860.08K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.